CXCL12 and myeloid sarcoma: Indeed, in both MS and EAE, the intravascular expression of CXCL12 was associated to the presence of intraluminal CXCR4+ adhering leukocytes as well as to CXCR4 expression on perivascular infiltrating leukocytes (McCandless et al., 2008).